Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma

Latest updates in exon 20 insertions focusing on targeted therapies, novel approaches, and implications for patients

COVID-19 and cancer: Highlights from ASCO 2021

PrE0807: Neoadjuvant nivolumab without or with lirilumab in cisplatin-ineligible patients with muscle-invasive bladder cancer

JAVELIN Bladder 100: Avelumab first-line maintenance plus best supportive care (BSC) versus BSC alone for advanced UC

Dose-escalation of mosunetuzumab with polatuzumab vedotin for R/R B-cell non-Hodgkin’s lymphoma

Efficacy and safety of tisagenlecleucel in adult patients with relapsed/refractory follicular lymphoma

Clinical research and trials in Romania

Medical and scientific days of The Institute of Oncology Bucharest 2021 : Steps to the Oncology of Tomorrow

Advances in lung cancer and current situation in Romania

First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukaemia

Breast cancer roundup from ASCO 2021